PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
PHAS
Delisted
PHAS was delisted on the 2nd of November, 2022.
61 hedge funds and large institutions have $110M invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 7 closing their positions.
Holders
61
Holders Change
+3
Holders Change %
+5.17%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
22
Reduced
17
Closed
7
Calls
$227K
Puts
$206K
Net Calls
+$21K
Net Calls Change
-$217K
